Index of reports
> Cases with Gastrointestinal Haemorrhage (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Torisel (Temsirolimus) where reactions include gastrointestinal haemorrhage. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Torisel side effects in 53 year old male
Reported by a physician from Japan on 2012-08-09
Patient: 53 year old male, weighing 65.0 kg (143.0 pounds)
Reactions: Gastrointestinal Haemorrhage, Stomatitis, Fungal Infection, Interstitial Lung Disease, Haemorrhagic Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torisel
Dosage: 25 mg, weekly
Indication: Metastatic Renal Cell Carcinoma
Start date: 2012-05-08
End date: 2012-07-10
Torisel
Indication: Metastases To Liver
Torisel
Indication: Metastases To Lung
Other drugs received by patient: Naproxen; Celebrex; Lansoprazole; Celebrex; Feburic
Possible Torisel side effects in 76 year old male
Reported by a physician from France on 2012-07-05
Patient: 76 year old male
Reactions: Gastrointestinal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torisel
Dosage: unk
Indication: Antiangiogenic Therapy
Start date: 2009-07-28
Torisel
Dosage: cycle 33
Start date: 2010-03-31
End date: 2010-03-31
Other drugs received by patient: Trandolapril; Atorvastatin; Novolog MIX 70 / 30; Prednisolone; Nebivolol HCL; Calcidia; Kardegic; Novorapid; Pantoprazole Sodium; Lasix
Possible Torisel side effects in 66 year old female
Reported by a physician from France on 2012-05-30
Patient: 66 year old female
Reactions: Gastrointestinal Haemorrhage, Febrile Neutropenia, Febrile Bone Marrow Aplasia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: unk
Indication: Mantle Cell Lymphoma
Start date: 2012-01-26
End date: 2012-01-30
Torisel
Indication: Mantle Cell Lymphoma Recurrent
Cyclophosphamide
Dosage: unk
Indication: Mantle Cell Lymphoma
Start date: 2012-01-26
End date: 2012-01-30
Torisel
Dosage: 25 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2012-01-27
End date: 2012-02-02
Prednisone TAB
Dosage: unk
Indication: Mantle Cell Lymphoma
Start date: 2012-01-26
End date: 2012-01-30
Rituximab
Dosage: unk
Indication: Mantle Cell Lymphoma
Start date: 2012-01-26
End date: 2012-01-30
Cyclophosphamide
Indication: Mantle Cell Lymphoma Recurrent
Vincristine Sulfate
Indication: Mantle Cell Lymphoma Recurrent
Prednisone TAB
Indication: Mantle Cell Lymphoma Recurrent
Cyclophosphamide
Dosage: unk
Indication: Mantle Cell Lymphoma
Start date: 2012-01-26
End date: 2012-01-30
Doxorubicin HCL
Indication: Mantle Cell Lymphoma Recurrent
Rituximab
Indication: Mantle Cell Lymphoma Recurrent
Possible Torisel side effects in 66 year old female
Reported by a individual with unspecified qualification from United States on 2012-05-25
Patient: 66 year old female
Reactions: Gastrointestinal Haemorrhage, Febrile Bone Marrow Aplasia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone TAB
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Torisel
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-27
End date: 2012-02-02
Rituximab
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Doxorubicin HCL
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Vincristine Sulfate
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Cyclophosphamide
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Possible Torisel side effects in 51 year old male
Reported by a physician from Switzerland on 2012-04-30
Patient: 51 year old male
Reactions: Gastrointestinal Haemorrhage
Drug(s) suspected as cause:
Torisel
Possible Torisel side effects in female
Reported by a physician from France on 2012-04-18
Patient: female
Reactions: Gastrointestinal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Torisel
Dosage: 25 mg, unk
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-27
End date: 2012-02-02
Doxorubicin HCL
Dosage: unk
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Prednisolone
Dosage: unk
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Cyclophosphamide
Dosage: unk
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Rituximab
Dosage: unk
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Vincristine Sulfate
Dosage: unk
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Possible Torisel side effects in 66 year old female
Reported by a physician from France on 2012-04-06
Patient: 66 year old female
Reactions: Gastrointestinal Haemorrhage, Febrile Bone Marrow Aplasia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Mantle Cell Lymphoma Recurrent
Rituximab
Dosage: unk
Indication: Mantle Cell Lymphoma
Start date: 2012-01-26
End date: 2012-01-30
Cyclophosphamide
Dosage: unk
Indication: Mantle Cell Lymphoma
Start date: 2012-01-26
End date: 2012-01-30
Prednisone
Indication: Mantle Cell Lymphoma Recurrent
Doxorubicin HCL
Dosage: unk
Indication: Mantle Cell Lymphoma
Start date: 2012-01-26
End date: 2012-01-30
Vincristine Sulfate
Indication: Mantle Cell Lymphoma Recurrent
Cyclophosphamide
Indication: Mantle Cell Lymphoma Recurrent
Torisel
Dosage: 25 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2012-01-27
End date: 2012-02-02
Vincristine Sulfate
Dosage: unk
Indication: Mantle Cell Lymphoma
Start date: 2012-01-26
End date: 2012-01-30
Prednisone
Dosage: unk
Indication: Mantle Cell Lymphoma
Start date: 2012-01-26
End date: 2012-01-30
Torisel
Indication: Mantle Cell Lymphoma Recurrent
Rituximab
Indication: Mantle Cell Lymphoma Recurrent
Possible Torisel side effects in 66 year old female
Reported by a physician from France on 2012-03-19
Patient: 66 year old female
Reactions: Gastrointestinal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: unk
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Vincristine Sulfate
Dosage: unk
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Cyclophosphamide
Dosage: unk
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Prednisolone
Dosage: unk
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Doxorubicin HCL
Dosage: unk
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-26
End date: 2012-01-30
Torisel
Dosage: 25 mg, unk
Indication: Mantle Cell Lymphoma Recurrent
Start date: 2012-01-27
End date: 2012-02-02
|